Biotech Values

[Biowatch]

The WYE purchase was probably cheap, given they'd bought American Home Products AHP, which tanked following the substantial drop in sales of hormone replacement therapies in postmenopausal women, after reports of increased cancer and heart attack risk. WYE or AHP must have had income, patents, employees, and other products that made it attractive, if only from a consolidation/shutting down the competition standpoint.